Abbott Laboratories Net Income 2007–2025
Abbott Laboratories reported $6.52B of net income for fiscal 2025. That was 51.3% lower than fiscal 2024. Compared with fiscal 2020, the change was +45.1%.
| Fiscal year | Net Income | Net margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $6.52B | 14.7% | -51.3% |
| FY 2024 | $13.40B | 31.9% | +134.2% |
| FY 2023 | $5.72B | 14.3% | -17.5% |
| FY 2022 | $6.93B | 15.9% | -2.0% |
| FY 2021 | $7.07B | 16.4% | +57.3% |
| FY 2020 | $4.50B | 13.0% | +21.9% |
| FY 2019 | $3.69B | 11.6% | +55.7% |
| FY 2018 | $2.37B | 7.7% | +396.4% |
| FY 2017 | $477.00M | 1.7% | -65.9% |
| FY 2016 | $1.40B | 6.7% | -68.3% |
| FY 2015 | $4.42B | 21.7% | +93.7% |
| FY 2014 | $2.28B | 11.3% | -11.3% |
| FY 2013 | $2.58B | 13.1% | -56.8% |
| FY 2012 | $5.96B | 31.3% | +26.1% |
| FY 2011 | $4.73B | 22.1% | +2.2% |
| FY 2010 | $4.63B | 13.2% | -19.5% |
| FY 2009 | $5.75B | 18.7% | +17.7% |
| FY 2008 | $4.88B | 16.5% | +35.3% |
| FY 2007 | $3.61B | 13.9% | — |
Source: Abbott Laboratories SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open ABT 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Abbott Laboratories reported $6.52B of net income for fiscal 2025. That was 51.3% lower than fiscal 2024. Compared with fiscal 2020, the change was +45.1%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Abbott Laboratories
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeAbbott Laboratories — frequently asked questions
What is Abbott Laboratories's net income?
Abbott Laboratories (ABT) reported net income of $6.52B for fiscal year 2025, per its SEC filings.
How has Abbott Laboratories's net income changed over time?
Between fiscal 2007 and 2025, ABT's net income grew at roughly 3.3% per year (compound annual rate), from $3.61B to $6.52B.
Where does this data come from?
Figures are computed from Abbott Laboratories's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.